Phase IB study of sorafenib + evofosfamide in patients with advanced hepatocellular carcinoma (HCC) and renal cell carcinoma NCCTG N1153 (Alliance)
- Citation:
- Ann Oncol vol 27 (2) abstr P-100
- Meeting Instance:
- ESMO GI 2016
- Year:
- 2016
- Type:
- Abstract
- Sub type:
- Poster General
- Funding:
- NCTN
- Endpoint:
- Primary
- Analysis:
- Preliminary
- Data Sharing:
- No-Data-Sharing
- Status:
- Presented/Published
- Citation Status:
- ppub
- Note:
- Methodological:
- No
- Biospecimen:
- No
- SDC:
- No
- Parents:
- None
- Children:
- 3530
- Program:
- OGC
- Primary Committee:
- Experimental
- Sec. Committees:
- Pharmas:
- Grants:
- U10CA180821, U10CA180882
- Corr. Author:
- Authors:
- Mitesh J. Borad Nathan R. Foster Peter R. Martin Steven Alberts Joleen Hubbard Alvin Silva Thorvardur Halfdanarson Charles Erlichman
- Networks:
- LAPS-MN026, METROMIN
- Study
- NCCTG-N1153
- Multiple Studies, or Legacy Studies in Alliance Study:
- Phases:
- 1
- Keywords: